PET scanning and measuring the impact of treatment

被引:20
作者
Cohade, C [1 ]
Wahl, RL [1 ]
机构
[1] Johns Hopkins Univ Hosp, Div Nucl Med, Russel H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21287 USA
关键词
PET; FDG; fluorodeoxyglucose; cancer; response; therapy; radionuclide imaging; positron emission tomography;
D O I
10.1097/00130404-200203000-00006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Positron emission tomography (PET) scanning with F18-fluorode-oxyglucose or FDG is a becoming a standard method for tumor staging. The prediction and evaluation of therapy response are newer applications of FDG-PET, PET often offers an early read-out of treatment efficacy and is an attractive alternative to conventional anatomic assessments of treatment response. This article reviews the methods available with PET to monitor therapy response. Disease specific applications of PET imaging are then reviewed. While FDG is the most commonly used radiotracer for PET, many other radioligands could be applied in the future.
引用
收藏
页码:119 / 134
页数:16
相关论文
共 114 条
[1]  
Ahuja V, 1998, CANCER, V83, P918, DOI 10.1002/(SICI)1097-0142(19980901)83:5<918::AID-CNCR17>3.3.CO
[2]  
2-#
[3]   Recurrence of head and neck cancer after surgery or irradiation: Prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses [J].
Anzai, Y ;
Carroll, WR ;
Quint, DJ ;
Bradford, CR ;
Minoshima, S ;
Wolf, GT ;
Wahl, RL .
RADIOLOGY, 1996, 200 (01) :135-141
[4]  
Bassa P, 1996, J NUCL MED, V37, P931
[5]   Possible role of FDG-PET in the early prediction of therapy outcome in liver metastases of colorectal cancer [J].
Bender, H ;
Bangard, N ;
Metten, N ;
Bangard, M ;
Mezger, J ;
Schomburg, A ;
Biersack, HJ .
HYBRIDOMA, 1999, 18 (01) :87-91
[6]   PILOT-STUDY OF POSITRON EMISSION TOMOGRAPHY IN PATIENTS WITH ADVANCED HEAD AND NECK-CANCER RECEIVING RADIOTHERAPY AND CHEMOTHERAPY [J].
BERLANGIERI, SU ;
BRIZEL, DM ;
SCHER, RL ;
SCHIFTER, T ;
HAWK, TC ;
HAMBLEN, S ;
COLEMAN, RE ;
HOFFMAN, JM .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 1994, 16 (04) :340-346
[7]  
Bogart JA, 1998, CANCER-AM CANCER SOC, V82, P754, DOI 10.1002/(SICI)1097-0142(19980215)82:4<754::AID-CNCR19>3.0.CO
[8]  
2-X
[9]  
Brock CS, 2000, BRIT J CANCER, V82, P608
[10]  
Brücher BLDM, 2001, ANN SURG, V233, P300